Company intelligence / Profile preview

STgenetics

Navasota, Texas, United Statesstgen.com ↗

Ownership: Private
Development stage: Commercial

Overview

STgenetics has pioneered commercial gender-sorted semen technology based on DNA content differences between X/Y chromosomes. The company also offers advanced genomic testing to accelerate genetic progress in dairy/beef herds. Its EcoFeed™ program enables selection of animals with superior feed efficiency—reducing both input costs and methane emissions by up to 20% per generation. No gene editing or transgenic methods are used; all improvements leverage natural genetic variation with advanced analytics.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on STgenetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STgenetics.

Explore the full profile